eHealth, Inc. revised earnings guidance for the full year ending December 31, 2023. Total revenue is expected to be in the range of $439 million to $459 million compared to prior guidance of $420 million to $440 million. GAAP net loss is expected to be in the range of $46 million to $26 million compared to prior guidance of $55 million to $35 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.35 USD | -5.31% | -8.39% | -38.65% |
05-30 | EHealth CFO John Stelben to Retire; John Dolan Named Successor | MT |
05-30 | EHealth, Inc. Appoints John Dolan as SVP and Principal Financial and Accounting Officer, Effective August 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.65% | 165M | |
-2.24% | 61.15B | |
+13.49% | 55.29B | |
+5.78% | 26.07B | |
+26.42% | 25.36B | |
+13.49% | 8.35B | |
+31.33% | 6.76B | |
-6.19% | 4.09B | |
0.00% | 3.32B | |
+9.08% | 2.32B |
- Stock Market
- Equities
- EHTH Stock
- News eHealth, Inc.
- EHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023